Abbott has received a CE mark for a system that senses both glucose and ketone levels. This technology is reportedly the first of its kind and may have implications for people with diabetes, potentially aiding in the prevention of diabetic ketoacidosis. The CE mark indicates clearance for use in Europe, though it is unclear when or if the technology will be available in other regions.